Lilly presents impressing results for Alzheimer’s drug donanemab
Eli Lilly’s Alzheimer’s drug donanemab has speedy removed amyloid plaques in a pivotal Phase III trail halting disease progression for one year in half of patients.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Biomethane fuel offers negative carbon footprint
/in News/by Thomas GabrielczykAlthough the EU Commission wants to abolish the internal combustion engine in individual transport through eMobility, biofuels are far from dead, according to a new study.
Carbios raises 141m to boost enzymatic PET recycling
/in News/by Thomas GabrielczykIn an oversubscribed capital increase, Carbios SAS has raised 141m, the largest on Euronext growth since 2015.
EG 427 expands Series A closing to 18m
/in News/by Thomas GabrielczykParis-based gene therapy vector specialist EG 427 SAS has closed a Series A financing at 18m raising additional 5m in the final closing.
Seed money for unique topical hair growth inducer
/in News/by Thomas GabrielczykMallia Therapeutics GmbH has raised seed money to accelerate preclinical research and start Phase I testing of a baldness cure with unique MOA named soluble CD83.
Evotec earns US$40m in global licence deal with BMS
/in News/by Thomas GabrielczykGerman CRO Evotec SE enters licence agreement Bristol Myers Squibb within its neuroscience partnership providing US$40m upfront, milestones and double-digit sales royalities.
Nanobiotix SA licences NBTXR3 to J&J
/in News/by Thomas GabrielczykParis-based Nanobiotix SA has signed a potential US$1.8bn oncology deal with Janssen Pharmaceutica NV for the global commercialisation rights of its radioenhancer NBTXR3.
Living therapy: Microbial immunotherapy of Exeliom Biosciences gets a boost
/in News/by Thomas GabrielczykExeliom Biosciences, a French company focused on the microbiome-immunomodulation axis to develop next-generation immunotherapies, has announced the closing of its 24m (US$26m) Series A financing to advance the clinical development […]
Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlands
/in News/by Thomas GabrielczykIt is just announced that it will soon be possible to taste farmed meat and seafood in the Netherlands under controlled conditions. The Dutch government, in collaboration with cultured meat […]